Latest research on Capecitabine

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Capecitabine and alcohol

Supportive care measures should be initiated at the start of Capecitabine therapy to reduce the severity of PPE: applying alcohol-free emollient lotions to the palmar and plantar surfaces 1 to 2 times per day, avoiding aggravating factors (friction, heat, exfoliating manicures or pedicures), and wearing supportive shoes with thick cotton socks. [source, 2012]